Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. - Wikidata - awgldk - TriplyDB

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

http://www.wikidata.org/entity/Q37358267

about

Bisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysis Development of bisphosphonates.Direct effects of bisphosphonates on breast cancer cells.Actions of bisphosphonates in animal models of breast cancer Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence Bisphosphonates in breast cancer Bisphosphonates induce apoptosis in human breast cancer cell lines Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.Anti-tumour activity of bisphosphonates in human myeloma cells.Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial.Bone-in-culture array as a platform to model early-stage bone metastases and discover anti-metastasis therapies Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?Bisphosphonates: from grandparents to grandchildren.Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results. International Bone and Cancer Study Group (IBCG).The potential role of bisphosphonates as adjuvant therapy in the prevention of bone metastases.Bisphosphonates and the prevention of metastasis: first evidences from preclinical and clinical studies.The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives.Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysis.NCCN Task Force Report: Bone Health in Cancer Care.Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders.The use of bisphosphonates in patients with breast cancer.The potential role of bisphosphonates in prostate cancer.Cytotoxic effect of clodronate and zoledronate on the chondrosarcoma cell lines HTB-94 and CAL-78 Tumour macrophages as potential targets of bisphosphonates.Injectable bisphosphonates in the treatment of postmenopausal osteoporosis.In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells.Advances in the use of bisphosphonates in the prostate cancer setting.Bisphosphonates and bone metastases: current status and future directions.Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment.Adjuvant pamidronate therapy prevents the development of bone metastases in breast cancer patients with four or more positive nodes.Skeletal complications of prostate cancer: pathophysiology and therapeutic potential of bisphosphonates.Ibandronate: efficacy in the treatment of metastatic bone disease.Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid.The anti-tumour effects of zoledronic acid The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells.New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects.Osteonecrosis of the jaw and bisphosphonates: a comparison with white phosphorus, radium, and osteopetrosis.

P2860

Q21132670-313DE086-1D92-4B8A-873B-7CD7060962D4 Q21195188-8F617D59-ED4C-4ECD-8CCB-4F3AA7CB49A4 Q24802079-27207F41-009D-42FD-9B6E-726EAA76B07C Q24802119-D1AB5D0A-F51C-47BB-B361-F3D863627AF8 Q26795493-79B130A5-FB98-4B80-B5AC-DE9AB5020AA1 Q26859326-2AF52777-88EB-4CF8-87E2-6C469D93713E Q28344185-2EF6EF09-D0C2-462B-9EF1-AAF068DD4E5E Q28361973-4B65C997-0EEA-4C50-95D1-03080325DDF4 Q28362972-63C02BB4-375C-4736-9F1D-3B9BC9D1193A Q33326045-B81EAAC4-3A4B-42B0-825A-6A02CE20FDCC Q33536291-F310468F-3310-4A87-BFEA-46FBF9DCA1AC Q33587199-87684507-DBBE-4B57-9BE3-CCE976E6238C Q33628894-4C5C3E03-25F9-4A55-BD58-E7A1DA942801 Q33739204-E8DE17F1-B7BB-48D1-99A4-5919BB1D1038 Q33807859-026A2499-6912-4131-966D-9F53931D3273 Q33898576-3091DCF9-96EB-4ACB-8F5A-6799536C0186 Q33970557-87373FDB-87CB-4E9B-9427-A29AA8EFB2CD Q33970595-6B6587C0-7433-4261-8A5E-83CDC8E3DE73 Q34145863-CC68286D-B716-4F08-9493-B2D8769EA094 Q34294905-6F50857B-551F-4633-A744-ABA4AD68F2F9 Q34583705-E6822022-45F0-4374-BD87-C6C08FA7AA9F Q34617936-727674A8-864F-4D03-AAA6-0FC8AD8F8A9C Q35000983-EA303DCA-4D47-4080-9076-418B3DCE247A Q35039488-B2750FC3-DE75-43EF-892D-B0C920427711 Q35081743-B9E46848-C6E2-4F2F-877D-532D78E1B2B1 Q35197773-AD15189E-FAAB-4600-AE2E-5BFCBAAD4A25 Q35547309-E7A95E64-9DFA-4028-953D-2330ABEDC1D2 Q35602572-727813F6-C1CC-4B71-9798-5F0DDE307896 Q35605757-27BB056A-FB36-4212-A9E5-2740AD8FFB8D Q35679766-281619F7-DFFF-41B3-B106-0F47C22057ED Q36118409-7EF11FDF-B41B-4532-BCD8-3C6A24E8C35D Q36194583-5D5454F4-7FBD-4905-8BB5-CF596F1BA1E5 Q36216730-58935667-267C-4090-BA5A-E2751672DCF6 Q36217148-33045CCB-AF3B-4C1C-8D8D-FD1E2D84AA5D Q36429562-A5A0AB28-ACA6-4A66-A997-D35D0D88F0E8 Q36459367-59CC655D-7BE2-44E0-B985-A8A587509E69 Q36491653-BA1DE9D9-BB28-4477-BAD9-11D94AC3D19D Q36644394-F6779C44-8E4E-41DA-A59E-8C616DA63779 Q36648924-76968E7A-3039-48BA-A807-E7D72FF09C3A Q36939499-36743D38-ED71-4516-9C47-A757BA096A5F

P2860

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

http://www.wikidata.org/entity/Q37358267

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 1996

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

@en

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

@nl

type

label

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

@en

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

@nl

prefLabel

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

@en

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

@nl

P1433

Q37358267-409A22BD-7CD3-4E8B-AD2F-23F58792812A

P1476

Q37358267-5FE5A896-D1C5-4E68-BBC6-4AB086545A53

P2093

Q37358267-12E3DFD1-A537-4C05-BA87-27C6173B6D70

Q37358267-7CCF1897-4623-430B-8D59-95D6B26BD8C1

Q37358267-832FA089-ADDE-460F-9BCF-C9216720900A

Q37358267-8D51CAEF-359C-45AC-A7DE-68695ACDB82A

Q37358267-A37F5484-C877-406E-91BE-AFE5F4189FFD

Q37358267-BD2C2716-677F-4CC8-B30F-0E1FEE75BABA

P2860

Q37358267-00775BB4-580B-44A9-8652-988E971F3D00

Q37358267-0504D74E-4A21-480F-A969-9DBB49C49D9C

Q37358267-0A86CDE4-C8D1-45B0-BD68-B41D394F9AB2

Q37358267-0F89B79D-F75C-4237-8F90-AF132ABA3FAF

Q37358267-0FD8FCF6-9AE1-4166-8C0C-B23CC99C6D44

Q37358267-25B4F86A-8B30-42DC-947C-8217DC9F3E7E

Q37358267-284B2CC7-DB49-43B6-8047-CE8DE6A52A7D

Q37358267-428E0771-2FE5-4061-B905-8BA6DC3A4C94

Q37358267-49431943-8621-4ABD-A067-CE1D636DA341

Q37358267-56AF9DE2-B1C8-447B-AB5A-73D7D532DDD1

P304

Q37358267-A38093EC-DBD2-4255-A5CB-20C7F023EE03

P31

Q37358267-61F45A97-C90F-46FF-9670-9C8BDB0A93D4

P356

Q37358267-9D02D563-4D66-48D9-AF4B-E83071DD77A4

P407

Q37358267-41E2DD9C-A8D0-46CE-9783-18D9CDA2F9F4

P433

Q37358267-CA5D5387-DDF9-486B-BD04-FB6CC99BEE89

P478

Q37358267-01AAAE9A-80C4-43A1-ADAA-C42F4E6F7C31

P577

Q37358267-AA054D19-883D-4689-AE38-95F9E36699D8

P698

Q37358267-82FD0693-38EC-4445-BF5B-A4744A097086

P932

Q37358267-D4E4E142-FAD8-4CAA-96D7-090093513691

P356

P1433

Journal of Clinical Investigation

P1476

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

@en

P2093

Löwik C

http://www.w3.org/2001/XMLSchema#string

Papapoulos S

http://www.w3.org/2001/XMLSchema#string

Vloedgraven H

http://www.w3.org/2001/XMLSchema#string

van Beek E

http://www.w3.org/2001/XMLSchema#string

van der Pluijm G

http://www.w3.org/2001/XMLSchema#string

van der Wee-Pals L

http://www.w3.org/2001/XMLSchema#string

P2860

Breast tumor cell lines from pleural effusions.

Resorption of bone by isolated rabbit osteoclasts.

The clinical course of bone metastases from breast cancer.

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.

Mechanisms of osteolytic bone destruction.

Rationale for the use of bisphosphonates in bone metastases.

Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment.

Bone metastases in breast cancer, prostate cancer and myeloma.

Osteolytic bone metastasis in breast cancer.

Mechanisms involved in the metastasis of cancer to bone.

P304

698-705

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI118841

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

1996-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8698861

http://www.w3.org/2001/XMLSchema#string

P932

507479

http://www.w3.org/2001/XMLSchema#string